deferoxamine has been researched along with Metabolic Diseases in 13 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rassu, G | 1 |
| Salis, A | 1 |
| Porcu, EP | 1 |
| Giunchedi, P | 1 |
| Roldo, M | 1 |
| Gavini, E | 1 |
| Kefala-Agoropoulou, K | 1 |
| Farmaki, E | 1 |
| Tsiouris, J | 1 |
| Roilides, E | 1 |
| Velegraki, A | 1 |
| Henretig, FM | 1 |
| Temple, AR | 1 |
| Morini, PL | 1 |
| Bianchi, MA | 1 |
| Borsotti, M | 1 |
| Brissot, P | 1 |
| Bourel, M | 1 |
| Simon, M | 1 |
| Fairbanks, VF | 1 |
| Kurihara, S | 1 |
| Marumo, F | 1 |
| Frol'kis, AV | 1 |
| Stromeyer, G | 1 |
| Stacher, A | 1 |
| Maas, B | 1 |
| Neth, R | 1 |
| Goschenhofer, D | 1 |
| Schäfer, KH | 1 |
| Cumming, RL | 1 |
| Millar, JA | 1 |
| Smith, JA | 1 |
| Goldberg, A | 1 |
| de Vries, SI | 1 |
2 reviews available for deferoxamine and Metabolic Diseases
| Article | Year |
|---|---|
[Inhibition of intestinal absorption as a principle of the treatment of metabolic diseases].
Topics: Animals; Anticholesteremic Agents; Biguanides; Deferoxamine; Dogs; Humans; Intestinal Absorption; Li | 1989 |
[Diseases caused by iron metabolism disorders and their therapy].
Topics: Adult; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Bloodletting; Deferoxamine; D | 1969 |
11 other studies available for deferoxamine and Metabolic Diseases
| Article | Year |
|---|---|
Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Topics: Alginates; Chemistry, Pharmaceutical; Chitosan; Deferoxamine; Delayed-Action Preparations; Drug Carr | 2016 |
Cutaneous zygomycosis in an infant with Pearson syndrome.
Topics: Amphotericin B; Anemia, Neonatal; Anemia, Sideroblastic; Antifungal Agents; Catheters, Indwelling; D | 2008 |
Acute iron poisoning in children.
Topics: Cardiovascular Diseases; Cathartics; Central Nervous System Diseases; Chemical and Drug Induced Live | 1984 |
[Comparison between serum ferritin and induced sideruria in the diagnosis of disorders of iron metabolism].
Topics: Adult; Aged; Deferoxamine; Female; Ferritins; Humans; Inflammation; Iron; Male; Metabolic Diseases; | 1981 |
[Treatment and prevention of chronic iron overload (author's transl)].
Topics: Bloodletting; Deferoxamine; Hematologic Diseases; Hemochromatosis; Hemosiderosis; Humans; Iron; Live | 1981 |
Chronic iron overload: new chelators and new strategies.
Topics: Anemia, Sideroblastic; Animals; Ascorbic Acid; Chelating Agents; Deferoxamine; Hemosiderosis; Humans | 1978 |
[Aluminum and iron deposition in dialysis patients].
Topics: Aluminum; Anemia; Bone Diseases, Metabolic; Deferoxamine; Erythropoietin; Humans; Iron; Kidney Failu | 1992 |
[Disorders of iron metabolism in liver patients].
Topics: Adult; Anemia; Biopsy; Deferoxamine; Feces; Female; Hemochromatosis; Humans; Iron; Iron Isotopes; Li | 1966 |
Microchemical measurement of urinary iron in infants and children.
Topics: Child; Child, Preschool; Deferoxamine; Humans; Infant; Iron; Metabolic Diseases; Methods | 1969 |
Clinical and laboratory studies on the action of desferrioxamine.
Topics: Animals; Deferoxamine; Diet; Feces; Ferritins; Hemochromatosis; Humans; Intestinal Mucosa; Iron; Kid | 1969 |
[Indications for treatment with Desferal].
Topics: Deferoxamine; Humans; Iron; Metabolic Diseases | 1966 |